These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34626045)

  • 1. A Meta-Analysis and Systematic Review on the Global Prevalence, Risk Factors, and Outcomes of Coronary Artery Disease in Liver Transplantation Recipients.
    Xiao J; Yong JN; Ng CH; Syn N; Lim WH; Tan DJH; Tan EY; Huang D; Wong RC; Chew NWS; Tan EXX; Noureddin M; Siddiqui MS; Muthiah MD
    Liver Transpl; 2022 Apr; 28(4):689-699. PubMed ID: 34626045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CAD-LT score effectively predicts risk of significant coronary artery disease in liver transplant candidates.
    Rachwan RJ; Kutkut I; Timsina LR; Bou Chaaya RG; El-Am EA; Sabra M; Mshelbwala FS; Rahal MA; Lacerda MA; Kubal CA; Fridell JA; Ghabril MS; Bourdillon PD; Mangus RS
    J Hepatol; 2021 Jul; 75(1):142-149. PubMed ID: 33476745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between coronary artery disease and cardiovascular events early after liver transplantation.
    Patel SS; Lin FP; Rodriguez VA; Bhati C; John BV; Pence T; Siddiqui MB; Sima AP; Abbate A; Reichman T; Siddiqui MS
    Liver Int; 2019 Jul; 39(7):1363-1371. PubMed ID: 30848862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Utility of a Risk-Adapted Protocol for the Evaluation of Coronary Artery Disease in Liver Transplant Recipients.
    Romero-Cristóbal M; Mombiela T; Caballero A; Clemente A; Fernández-Yunquera A; Diaz-Fontenla F; Rincón D; Ripoll C; Bermejo J; Catalina MV; Matilla AM; Ibáñez-Samaniego L; Pérez-Peña J; López-Baena JÁ; Díaz-Zorita B; Fernández-Avilés F; Salcedo MM; Bañares R
    Liver Transpl; 2019 Aug; 25(8):1177-1186. PubMed ID: 31106506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk stratification of myocardial injury after liver transplantation in patients with computed tomographic coronary angiography-diagnosed coronary artery disease.
    Moon YJ; Kwon HM; Jung KW; Jeong HW; Park YS; Jun IG; Song JG; Hwang GS
    Am J Transplant; 2019 Jul; 19(7):2053-2066. PubMed ID: 30653845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Coronary Artery Disease and Statins on Survival After Liver Transplantation.
    Patel SS; Rodriguez VA; Siddiqui MB; Faridnia M; Lin FP; Chandrakumaran A; Laurenzano J; Clinton J; Kowlgi GN; Kirkman D; Sima AP; Liptrap E; Bhati C; Siddiqui MS
    Liver Transpl; 2019 Oct; 25(10):1514-1523. PubMed ID: 31344758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review and meta-analysis on the impact of pre-existing and new-onset atrial fibrillation on outcomes before and after liver transplantation.
    So WZ; Tan FL; Tan DJH; Ng CH; Yong JN; Syn N; Tang ASP; Wong RC; Lin W; Tan EXX; Huang DQ; Dan YY; Chew NWS; Siddiqui MS; Muthiah MD
    Dig Liver Dis; 2022 May; 54(5):614-621. PubMed ID: 34896025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary artery disease in decompensated patients undergoing liver transplantation evaluation.
    Patel SS; Nabi E; Guzman L; Abbate A; Bhati C; Stravitz RT; Reichman T; Matherly SC; Driscoll C; Lee H; Luketic VA; Sterling RK; Sanyal AJ; Patel V; Levy M; Siddiqui MS
    Liver Transpl; 2018 Mar; 24(3):333-342. PubMed ID: 29328556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of Liver Transplant Recipients With Revascularized Coronary Artery Disease: A Comparative Analysis With and Without Cardiovascular Risk Factors.
    Satapathy SK; Vanatta JM; Helmick RA; Flowers A; Kedia SK; Jiang Y; Ali B; Eason J; Nair SP; Ibebuogu UN
    Transplantation; 2017 Apr; 101(4):793-803. PubMed ID: 28099403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of coronary calcium score in the risk assessment of liver transplant candidates.
    Kemmer N; Case J; Chandna S; Neff GW
    Transplant Proc; 2014; 46(1):230-3. PubMed ID: 24507057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial perfusion is impaired in asymptomatic renal and liver transplant recipients: a cardiovascular magnetic resonance study.
    Parnham S; Gleadle JM; Leong D; Grover S; Bradbrook C; Woodman RJ; De Pasquale CG; Selvanayagam JB
    J Cardiovasc Magn Reson; 2015 Jul; 17():56. PubMed ID: 26160365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and prediction of coronary artery disease in patients with liver cirrhosis: a registry-based matched case-control study.
    An J; Shim JH; Kim SO; Lee D; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS
    Circulation; 2014 Oct; 130(16):1353-62. PubMed ID: 25095888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Computed Tomography Coronary Calcium Score for Coronary Artery Disease Risk Stratification During Liver Transplant Evaluation.
    Bhatti S; Lizaola-Mayo B; Al-Shoha M; Garcia-Saenz-de-Sicilia M; Habash F; Ayoub K; Karr M; Ahmed Z; Borja-Cacho D; Duarte-Rojo A
    J Clin Exp Hepatol; 2022; 12(2):319-328. PubMed ID: 35535104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of Nonalcoholic Steatohepatitis After Liver Transplantation: An Updated Meta-Analysis and Systematic Review.
    Yong JN; Lim WH; Ng CH; Tan DJH; Xiao J; Tay PWL; Lin SY; Syn N; Chew N; Nah B; Dan YY; Huang DQ; Tan EXX; Sanyal AJ; Noureddin M; Siddiqui MS; Muthiah MD
    Clin Gastroenterol Hepatol; 2023 Jan; 21(1):45-54.e6. PubMed ID: 34801743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Meta-Analysis on the Global Prevalence, Risk factors and Screening of Coronary Heart Disease in Nonalcoholic Fatty Liver Disease.
    Toh JZK; Pan XH; Tay PWL; Ng CH; Yong JN; Xiao J; Koh JH; Tan EY; Tan EXX; Dan YY; Loh PH; Foo R; Chew NWS; Sanyal AJ; Muthiah MD; Siddiqui MS
    Clin Gastroenterol Hepatol; 2022 Nov; 20(11):2462-2473.e10. PubMed ID: 34560278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-Liver Transplant Cardiac Catheterization Is Associated With Low Rate of Myocardial Infarction and Cardiac Mortality.
    Kutkut I; Rachwan RJ; Timsina LR; Ghabril MS; Lacerda MA; Kubal CA; Bourdillon PD; Mangus RS
    Hepatology; 2020 Jul; 72(1):240-256. PubMed ID: 31696952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Coronary Angiography in Pre-Liver Transplantation Cardiac Evaluation: Experience From an Asian Transplant Institution.
    Pang NQ; Kow WCA; Law JH; Pan LTT; Lim BLK; Wong CCR; Chang KYS; Ganpathi IS; Madhavan K
    Transplant Proc; 2017 Oct; 49(8):1797-1805. PubMed ID: 28923628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac testing for coronary artery disease in potential kidney transplant recipients.
    Wang LW; Fahim MA; Hayen A; Mitchell RL; Baines L; Lord S; Craig JC; Webster AC
    Cochrane Database Syst Rev; 2011 Dec; 2011(12):CD008691. PubMed ID: 22161434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary artery disease in patients with liver cirrhosis.
    Kalaitzakis E; Rosengren A; Skommevik T; Björnsson E
    Dig Dis Sci; 2010 Feb; 55(2):467-75. PubMed ID: 19242795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of coronary artery disease on outcomes after liver transplantation.
    Skaro AI; Gallon LG; Lyuksemburg V; Jay CL; Zhao L; Ladner DP; VanWagner LB; De Wolf AM; Flaherty JD; Levitsky J; Abecassis MM; Gheorghiade M
    J Cardiovasc Med (Hagerstown); 2016 Dec; 17(12):875-885. PubMed ID: 25517876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.